Wednesday, September 25, 2019
- 1:15pm-2:45pm
-
No link between striatal dopaminergic axons and dopamine transporter imaging in Parkinson’s disease
Neuroimaging · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Non motor fluctuations in Parkinson’s disease: Findings from a Tunisian cohort
Non-Motor Symptoms · Agora 3 West, Level 3
- 1:15pm-2:45pm
-
Non motor symptoms Parkinson’s disease
Non-Motor Symptoms · Agora 3 West, Level 3
- 1:15pm-2:45pm
-
Non-Invasive Vagus Nerve Stimulation: A non-pharmacological approach to target gait impairment in Parkinson’s disease?
Non-Pharmacological Interventions · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Non-motor symptoms burden grading in Parkinson disease with the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS)
Non-Motor Symptoms · Agora 3 West, Level 3
- 1:15pm-2:45pm
-
Non-motor symptoms burden is greater in early Parkinson’s disease patients with motor complications
Non-Motor Symptoms · Agora 3 West, Level 3
- 1:15pm-2:45pm
-
Non-motor Symptoms in Hyperkinetic Movement Disorders
Non-Motor Symptoms · Agora 3 West, Level 3
- 1:15pm-2:45pm
-
Non-motor symptoms in Parkinson disease motor subtypes: a study using the new MDS-NMS
Non-Motor Symptoms · Agora 3 West, Level 3
- 1:15pm-2:45pm
-
Non-Motor Symptoms in Patients with Parkinson’s Disease: Effect of Gender, Disease Severity, and Disease Phenotype
Non-Motor Symptoms · Agora 3 West, Level 3
- 1:15pm-2:45pm
-
Nonmotor Symptoms in Parkinson’s Disease: 36-month Follow-up Study Comparing Bilateral Subthalamic Stimulation and Standard-of-care Medication
Non-Motor Symptoms · Agora 3 West, Level 3
- «Previous Page
- 1
- …
- 41
- 42
- 43
- 44
- 45
- …
- 67
- Next Page»